Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing

被引:0
|
作者
Sowmya, S. V. [1 ]
Augustine, Dominic [1 ]
Mushtaq, Shazia [2 ]
Baeshen, Hosam Ali [3 ]
Ashi, Heba [4 ]
Hassan, Reem Nabil [5 ]
Alshahrani, Mohammed [6 ]
Patil, Shankargouda [7 ]
机构
[1] MS Ramaiah Univ Appl Sci, Fac Dent Sci, Dept Oral Pathol & Microbiol, Bengaluru, Karnataka, India
[2] King Saud Univ, Coll Appl Med Sci, Dent Hlth Dept, Riyadh, Saudi Arabia
[3] King Abdulaziz Univ, Fac Dent, Dept Orthodont, Jeddah, Saudi Arabia
[4] King Abdulaziz Univ, Fac Dent, Dept Dent Publ Hlth, Jeddah, Saudi Arabia
[5] King Abdulaziz Univ, Fac Sci, Biol Sci Dept Genome, Jeddah, Saudi Arabia
[6] King Abdulaziz Univ, Fac Dent, Endodont Dept, Jeddah, Saudi Arabia
[7] Roseman Univ Hlth Sci, Coll Dent Med, South Jordan, UT USA
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
CRISPR-Cas9; gene editing; oral cancer; CRISPR-screens; genetic editing; POOLED IN-VITRO; CLINICAL-TRIAL; 1ST TRIAL; CRISPR/CAS9; CELLS; DELIVERY; PROGRESS; THERAPY; SYSTEM; TOOL;
D O I
10.3389/fonc.2024.1383062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review presents an in-depth analysis of the immense potential of CRISPR-Cas9 technology in revolutionizing oral cancer research. It underscores the inherent limitations of conventional treatments while emphasizing the pressing need for groundbreaking approaches. The unparalleled capability of CRISPR-Cas9 to precisely target and modify specific genes involved in cancer progression heralds a new era in therapeutic intervention. Employing genome-wide CRISPR screens, vulnerabilities in oral cancer cells can be identified, thereby unravelling promising targets for therapeutic interventions. In the realm of oral cancer, the disruptive power of CRISPR-Cas9 manifests through its capacity to perturb genes that are intricately associated with drug resistance, consequently augmenting the efficacy of chemotherapy. To address the challenges that arise, this review diligently examines pertinent issues such as off-target effects, efficient delivery mechanisms, and the ethical considerations surrounding germline editing. Through precise gene editing, facilitated by CRISPR/Cas9, it becomes possible to overcome drug resistance by rectifying mutations, thereby enhancing the efficacy of personalized treatment strategies. This review delves into the prospects of CRISPR-Cas9, illuminating its potential applications in the domains of medicine, agriculture, and biotechnology. It is paramount to emphasize the necessity of ongoing research endeavors and the imperative to develop targeted therapies tailored specifically for oral cancer. By embracing this comprehensive overview, we can pave the way for ground-breaking treatments that instill renewed hope for enhanced outcomes in individuals afflicted by oral cancer.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
    Gupta, Rajat M.
    Musunuru, Kiran
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (10): : 4154 - 4161
  • [32] Advances in and Perspectives on Transgenic Technology and CRISPR-Cas9 Gene Editing in Broccoli
    Zhang, Li
    Meng, Sufang
    Liu, Yumei
    Han, Fengqing
    Xu, Tiemin
    Zhao, Zhiwei
    Li, Zhansheng
    GENES, 2024, 15 (06)
  • [33] The Implications of CRISPR-Cas9 Genome Editing for IR
    Perkons, Nicholas R.
    Sheth, Rahul
    Ackerman, Daniel
    Chen, James
    Saleh, Kamiel
    Hunt, Stephen J.
    Nadolski, Gregory J.
    Shi, Junwei
    Gade, Terence P.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (09) : 1264 - 1267
  • [34] A Survey of Validation Strategies for CRISPR-Cas9 Editing
    Sentmanat, Monica F.
    Peters, Samuel T.
    Florian, Colin P.
    Connelly, Jon P.
    Pruett-Miller, Shondra M.
    SCIENTIFIC REPORTS, 2018, 8
  • [35] Development and Applications of CRISPR-Cas9 for Genome Editing
    Zhang, Feng
    HUMAN GENE THERAPY, 2014, 25 (11) : A10 - A10
  • [36] Gene Editing of Human Hepatocytes by CRISPR-Cas9
    Zhang, Qingshuo
    Tiyaboonchai, Amita
    Balaji, Niveditha
    Naugler, Willscott
    Grompe, Markus
    MOLECULAR THERAPY, 2018, 26 (05) : 367 - 367
  • [37] CRISPR-Cas9 Mediated Genome Editing in Drosophila
    Peng, Ping
    Wang, Xia
    Shen, Da
    Sun, Jin
    Jia, Yu
    Xu, Rong-Gang
    Zhu, Li-Fei
    Ni, Jian-Quan
    BIO-PROTOCOL, 2019, 9 (02):
  • [38] A Survey of Validation Strategies for CRISPR-Cas9 Editing
    Monica F. Sentmanat
    Samuel T. Peters
    Colin P. Florian
    Jon P. Connelly
    Shondra M. Pruett-Miller
    Scientific Reports, 8
  • [39] CRISPR-Cas9 Genome Editing of Plasmodium knowlesi
    Mohring, Franziska
    Hart, Melissa N.
    Patel, Avnish
    Baker, David A.
    Moon, Robert W.
    BIO-PROTOCOL, 2020, 10 (04):
  • [40] Photoactivatable CRISPR-Cas9 for optogenetic genome editing
    Nihongaki, Yuta
    Kawano, Fuun
    Nakajima, Takahiro
    Sato, Moritoshi
    NATURE BIOTECHNOLOGY, 2015, 33 (07) : 755 - 760